REG - Redx Pharma plc - Director/PDMR Shareholding

Redx PharmaAnnouncement

01/07/2020 12:30

RNS Number : 7371R
  
Redx Pharma plc
  
01 July 2020
  
 

REDX PHARMA PLC
("Redx" or "the Company")
 
Share Purchases by Directors
 
Alderley Park, 1 July 2020 - Redx Pharma (AIM:REDX), the drug discovery and development Group focused on cancer and fibrosis, announces that it has been notified that Iain Ross, Non-executive Chairman, has on Tuesday 30 June acquired 215,870 Redx ordinary shares at the following prices: 
 




Number of Ordinary shares purchased


Price per share (pence)




86,881


17.25




53,989


18.50




35,000


19.75




40,000


22.50




 
Following this, Mr Ross will hold 215,870 ordinary shares in the Company, representing 0.11 per cent. of the issued share capital.
 
The Company also announces that Non-Executive Director Mr Peter Presland has on Tuesday 30 June acquired 118,849 Redx ordinary shares at a price of 25 pence per share. Mr Presland purchased the shares through his self-invested personal pension (SIPP).  Following this, Mr Presland will hold 118,849 ordinary shares in the Company, representing 0.06 per cent of the issued share capital.
 
-Ends-
 
For further information, please contact:
 




Redx Pharma Plc


T: +44 1625 469 918




Lisa Anson, Chief Executive Officer
James Mead, Chief Financial Officer


 




 


 




SPARK Advisory Partners (Nominated Advisor)


 T: +44 203 368 3550




Matt Davis/ Henry Todd


 




 


 




WG Partners LLP (Broker)


T: +44 20 3705 9330




Claes Spång/ Chris Lee/ David Wilson


 




 


 




 


 




FTI Consulting


T: +44 20 3727 1000




Simon Conway/Ciara Martin


 




 
About Redx Pharma Plc 
Redx is a UK biotechnology Group whose shares are traded on AIM (AIM:REDX). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.
 
 




Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014




1


Details of the person discharging managerial responsibilities/person closely associated




a.


Name


Iain Ross




2


Reason for notification


 
 
 




a.


Position/Status


Non -Executive Chairman




b.


Initial notification/
Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a.


Name


Redx Pharma Plc




b.


LEI


213800HMS4EBXO589Y37




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a.


Description of the financial instrument, type of instrument



Identification Code


Ordinary Shares of 1p each



 
ISIN: GB00BSNB6S51




b.


Nature of the transaction


Purchase




c.


Price(s) and volume(s)


86,881 at 17.25 pence per share
53,989 at 18.50 pence per share
35,000 at 19.75 pence per share
40,000 at 22.50 pence per share




d.


Aggregated information
- Aggregated Volume
- Price


215,870 at 18.94 pence per share




e.


Date of the transaction


30/06/20




f.


Place of the transaction


Outside of trading venue




 
 
 




Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014




1


Details of the person discharging managerial responsibilities/person closely associated




a.


Name


Peter Presland




2


Reason for notification


 
 
 




a.


Position/Status


Non-executive Director




b.


Initial notification/
Amendment


Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a.


Name


Redx Pharma Plc




b.


LEI


213800HMS4EBXO589Y37




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a.


Description of the financial instrument, type of instrument



Identification Code


Ordinary Shares of 1p each



 
ISIN: GB00BSNB6S51




b.


Nature of the transaction


Purchase




c.


Price(s) and volume(s)


118,849
 
25 pence




d.


Aggregated information
- Aggregated Volume
- Price


N/A - Single Transaction




e.


Date of the transaction


30/06/20




f.


Place of the transaction


Outside of trading venue




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHUAUARRNUBRAR